Christopher Pechock is Director at MYOS RENS TECHNOLOGY INC. (MYOS). They have made 5 open-market trades across 3 companies since 2007, most recently 2020-03-31.
CIK 0001257448
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $3.2M since 2008, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYOS | BUY | 2020-03-05 | 2020-03-09 | $1.21 | $200K | -27.7% | -21.4% | -22.8% |
| MYOS | BUY | 2019-03-27 | 2019-03-27 | $1.46 | $100K | +8.4% | -7.9% | +13.0% |
| MYOS | BUY | 2018-04-25 | 2018-04-27 | $1.24 | $200K | +19.2% | +19.2% | -5.4% |
| BPSG | BUY | 2008-03-04 | 2008-03-07 | $1.70 | $2.7M | N/A | N/A | N/A |
| HUN | SELL | 2007-08-06 | 2007-08-08 | $24.25 | $1.4B | -21.5% | -1.5% | -1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.